United States Keloid Treatment Market Set to Surge: Innovative Therapies Driving Global Growth 2025 | Major key players - Novartis AG, GlaxoSmithKline Plc., Revitol Corporation.

Market Overview:

The Keloid Treatment Market is expected to reach at a CAGR of 9.9% during the forecast period (2024-2031). The Market is growing due to the rising prevalence of keloid scars, increasing awareness of advanced treatment options, and growing demand for cosmetic and dermatological procedures.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/keloid-treatment-market?sz

The Keloid Treatment Market encompasses therapies, medications, and medical devices designed to prevent, reduce, or remove keloid scars abnormal, raised tissue formations resulting from excessive collagen during wound healing. It includes surgical interventions, corticosteroid injections, laser therapies, silicone gels, and emerging biologics. The market is driven by rising cosmetic concerns, increasing prevalence of keloids, and demand for minimally invasive, effective scar management solutions.

Industry Recent Developments:

United States:

✅ There is growing demand for advanced keloid treatments such as corticosteroid injections, cryotherapy, laser therapy, and emerging biologics driven by increased awareness and aesthetic concerns. (August 2025)

✅ Personalized and combination therapies, including minimally invasive laser procedures combined with corticosteroid injections or silicone sheeting, are gaining traction to improve treatment outcomes. (September 2025)

✅ Teledermatology is expanding access to keloid treatments in remote areas, offering effective scar management options beyond traditional clinical settings. (October 2025)

Japan:

✅ The Japanese market is experiencing significant growth due to rising awareness of advanced scar treatment options and increasing demand for non-invasive therapies, such as laser and silicone-based treatments, along with corticosteroid injections (August-September 2025).

✅ Personalized treatment plans tailored to individual scar types and patient needs are becoming more common in Japan, enhancing therapy effectiveness and patient satisfaction (September 2025).

✅ Japan's strong skincare and beauty culture is contributing to higher adoption rates of keloid and hypertrophic scar treatments, with emphasis on improving aesthetic outcomes and broadening available treatment options (October 2025).

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/keloid-treatment-market?sz

FDA Approvals and Regulatory Updates:

Microneedling Devices: On October 15, 2025, the FDA authorized microneedling devices for improving the appearance of facial acne scars, facial wrinkles, and abdominal scars in patients aged 22 years or older. This approval indicates the FDA's recognition of microneedling as a safe and effective treatment modality for certain types of scars.

Kenalog (Triamcinolone Acetonide): Kenalog remains FDA-approved for intralesional administration specifically for keloids. This corticosteroid is commonly used to reduce scar size, thickness, and redness when injected directly into keloid lesions.

SRT-100 Vision: The SRT-100 Vision is FDA-approved for treating keloids caused by surgery or injury. It utilizes superficial radiation therapy to effectively manage keloid scars.

Research and Clinical Developments:

Ritlecitinib Trials: Mount Sinai is conducting clinical trials on ritlecitinib, a JAK3/TEC inhibitor, for patients with keloids or those undergoing keloidectomy. The study aims to assess the potential of ritlecitinib in reversing both systemic and local keloid disease processes by re-establishing immune homeostasis.

Syntara Limited's SATELLITE Trial: Syntara Limited has initiated the SATELLITE Phase 1c trial for keloid scars, dosing the first patient in July 2025. The trial involves up to 20 participants aged 18 years and above with active keloids measuring between 5 and 25 cm2, evaluating the efficacy and safety of the treatment.

Major Key Players:

Bristol-Myers Squibb Company
Valeant Pharmaceuticals International Inc.
Renovo Group Plc
Galena Biopharma Inc.
Pacific World Corporation
Novartis AG
GlaxoSmithKline Plc.
RXi Pharmaceuticals Inc.
Revitol Corporation
Avita Medical Limited.

Segments Covered in the Keloid Treatment Market:

By Product Type: Elastic Wraps, Sprays, Ointment, Creams, Oils, Topical Gels & Gel Sheets, Others.

By Treatment Type: Radiation Therapy, Cryo Therapy, Surgical Treatment, Laser Treatment, Steroid Injections, Interferon Therapy, Others.

By End-User: Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, Others.

By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=keloid-treatment-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Keloid Treatment market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Keloid Treatment Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Keloid Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Keloid Treatment Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Keloid Treatment Market in 2025?
◆ What is the projected growth rate of the Keloid Treatment Market through 2033?
◆ Who are the key players in the Keloid Treatment Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.